This is a genetic condition where your body doesn't have enough of an enzyme called G6PD. This enzyme helps protect red blood cells from damage. Without enough G6PD, red blood cells can break down too quickly, leading to anemia.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
G6PD deficiency is an inherited condition in which red blood cells have too little of an enzyme called glucose-6-phosphate dehydrogenase (G6PD). This enzyme protects red blood cells from chemical damage known as oxidative stress. Without enough of it, red blood cells can break apart early when the body meets certain triggers, such as an infection, some medicines or fava beans. This breakdown is called hemolysis, and when red cells are destroyed faster than the body can replace them, the result is hemolytic anemia. Most people with G6PD deficiency feel completely well and may not know they have it until a trigger causes an episode. During an episode, a person may become pale, tired and short of breath, notice a fast heartbeat, develop yellowing of the skin or whites of the eyes (jaundice) or pass dark urine. In newborns, G6PD deficiency is an important cause of jaundice, which can become severe. It is one of the most common inherited enzyme conditions in the world, affecting an estimated 400 million people, including about 1 in 10 African American males in the United States. A very rare, more severe form causes ongoing anemia even without a trigger.
G6PD deficiency is caused by changes (variants) in the G6PD gene, which sits on the X chromosome. Males have one X chromosome, so a male with an affected copy has the condition. Females have two, so one affected copy may cause no problems, a mild deficiency or a deficiency as marked as a male's, depending on how many of their red blood cells rely on the affected copy. A father cannot pass the condition to his sons. The condition is most common in people with roots in parts of Africa, Asia, the Mediterranean and the Middle East. These are regions where malaria has been widespread, and carrying a G6PD variant appears to offer some protection against dying from malaria, which helps explain why the variants became common. The gene variant creates the vulnerability, but an episode usually needs a trigger. Infections, bacterial or viral, are a frequent one. Eating fava beans (broad beans) can cause a severe episode, a reaction known as favism, and inhaling pollen from fava plants can do the same. Certain chemicals, such as naphthalene in mothballs, can also trigger hemolysis. A short list of medicines carries a well-established risk. These include the antimalarials primaquine (at standard doses; lower doses are sometimes used under medical supervision) and tafenoquine, dapsone (an antibiotic also used for some skin conditions), rasburicase and pegloticase (enzyme drugs that lower uric acid), and methylene blue (a hospital medicine used mainly to treat methemoglobinemia, a blood problem that limits oxygen delivery, and also sold online as a wellness supplement). Phenazopyridine, the urinary pain reliever sold over the counter as AZO Urinary Pain Relief, is on the same list. Nitrofurantoin, a common antibiotic for bladder infections, is used with caution, so a prescriber may choose another antibiotic or watch for signs of hemolysis. Many other medicines appear on older avoid lists based on thin evidence. A 2022 guideline from the Clinical Pharmacogenetics Implementation Consortium (CPIC), an expert group that turns genetic results into prescribing advice, found that very widely used drugs such as low-dose aspirin and sulfamethoxazole (the sulfa antibiotic in Bactrim) do not appear to raise the risk. Checking a specific medicine with a prescriber or pharmacist is more reliable than a long list found online.
G6PD deficiency is diagnosed with a blood test that measures how much G6PD enzyme activity red blood cells have. People are usually tested after an episode of hemolytic anemia or newborn jaundice, because a relative has the condition, or before starting a medicine that is risky with the deficiency. Tafenoquine (Krintafel), for example, must not be given to anyone whose G6PD status is unknown. In the United States, G6PD is not part of the standard national newborn screening panel, although some states and hospitals test for it. Timing affects the result. Shortly after an episode, the newest red blood cells carry more enzyme than older ones, and after a blood transfusion much of the circulating blood comes from a donor. Either situation can make a deficient person's test look normal, so a normal result taken at those times may need repeating once the blood has recovered. Genetic testing can identify G6PD variants, but it has limits. Many tests look only for common variants, so a negative result does not rule out the condition. In females with one affected copy, a gene test cannot predict how much working enzyme they actually have, so an enzyme activity test is needed to know their risk.
There is no treatment that corrects the enzyme deficiency itself. Care centers on preventing episodes and treating them promptly when they happen. Prevention does most of the work. That means avoiding fava beans and the higher-risk medicines, checking any new prescription or over-the-counter product with a prescriber or pharmacist, and making sure the diagnosis is in your medical records so it is considered before medicines are given in a hospital or emergency. Infections still need prompt treatment, because the infection itself can trigger hemolysis. When an episode happens, the first steps are stopping the trigger and treating any infection. Blood counts usually recover as the body makes new red blood cells, and a person with severe anemia may need a blood transfusion. Newborns with significant jaundice are commonly treated with phototherapy, a light treatment that helps the body clear bilirubin, the yellow pigment released when red cells break down.
G6PD deficiency is lifelong, but for most people it has little effect on day-to-day life. Many never have an episode, and the main change after diagnosis is a habit: telling every new clinician, dentist and pharmacist about it, and checking medicines and remedies before using them. This matters most during illness, surgery, cancer treatment or travel to an area with malaria, when higher-risk medicines are more likely to come up. When an episode does occur, it is usually temporary. Blood counts recover once the trigger is removed and the body replaces the lost cells, although some episodes are severe enough to need hospital care. How serious an episode becomes depends on the variant, the trigger and the dose. Because the condition is inherited, relatives may want testing, and a woman's risk cannot be assumed from family history alone. For a baby born into a family with G6PD deficiency, letting the birth team know helps them watch closely for jaundice in the first days of life.
Arrange a visit to discuss testing if a relative has G6PD deficiency, if you have had unexplained anemia or jaundice, or before taking a medicine your prescriber says needs a G6PD test first. Contact your care team the same day if, after an infection, a new medicine or eating fava beans, you notice dark urine, yellowing of the skin or eyes, unusual paleness, or new tiredness with shortness of breath. Hemolysis is treated most effectively when it is recognized promptly. A newborn who looks yellow, or is hard to wake or not feeding well, should also be checked by the baby's clinician that day, since jaundice linked to G6PD deficiency can become severe and, untreated, can cause permanent brain damage (kernicterus). Seek emergency care for shortness of breath at rest, fainting or confusion during an episode, which can signal severe anemia.
Last reviewed • Oct 2026
Educational content, not medical advice.
I live with G6PD deficiency, and I’d like to hear how others manage everyday decisions about medications and food. What reliable resources have helped you, and how do you check conflicting information with your doctor or pharmacist? I also manage epilepsy, so finding information that considers more than one condition matters to me.